The US drugmaker seeks to boost its cancer drug pipeline
Europes Front Line Is Preparing for War
...
Read moreDetailsHome » Gilead to buy US biotech Arcellx for up to US$7.8 billion
The US drugmaker seeks to boost its cancer drug pipeline
...
Read moreDetails...
Read moreDetails